Plain-English translation of NCT07303439 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new approach to treating blocked heart arteries in people with diabetes. Researchers want to compare three treatment strategies: using a drug-coated balloon (called Pantera® Lux®) combined with a drug-eluting stent (called Orsiro®), using the balloon alone, or using the stent alone. The goal is to find out which approach is safest and most effective at keeping arteries open long-term.
People with diabetes have a higher risk of their treated arteries becoming blocked again after treatment. This trial exists to see whether combining two devices might prevent this problem better than using just one device alone.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive one of three treatments during a heart catheterization procedure. After treatment, you will need to take blood-thinning medications for 6 to 12 months and return for follow-up visits to check how well your treatment is working. The study will track your heart health over time to see which treatment approach works best for people with diabetes.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
Ireland